Praetorian Acquisition Business Summary

Praetorian Acquisition Corp. (PTOR) is a special purpose acquisition company (SPAC) that generates revenue primarily through non-operating interest income derived from its $220 million initial public offering proceeds held in trust. The company operates without a traditional product-based business segment, instead focusing its entire operational capacity on identifying and merging with a target enterprise in a "traditional" sector—such as healthcare, logistics, or industrial services—that can be fundamentally transformed via artificial intelligence and automation. PTOR competes for high-quality private targets and investor capital against other specialized blank-check vehicles, including GigCapital9 Corp (GIXX.U), Colombier Acquisition Corp. III (CLBR.U), and Archimedes Tech SPAC Partners II (ATII.U). Within this landscape, PTOR positions itself as a strategic bridge for legacy businesses seeking to modernize their operations through AI-driven efficiencies. The company is led by CEO and Chairman Justin Di Rezze, M.D., the founder of Theoria Medical, a prominent healthcare technology and physician services organization. He is supported by CFO Peter Ondishin, a seasoned capital markets executive who also serves as CFO of Inflection Point Acquisition Corp. III and has held senior financial roles at The Venture Collective and Kingstown Capital Management. PTOR’s board of directors features a high-pedigree assembly of industry leaders, including Nicole Seligman, former President of Sony Entertainment and Sony Corporation of America; Alex Elias, founder and CEO of the AI-focused Luma; and Erica Dorfman, Head of Global Financial Products at Brex. This leadership team combines deep domain expertise in healthcare, fintech, and artificial intelligence with a proven track record in complex capital markets and technology-centric transactions.